Restoration of innate host defense responses by oral supplementation of branched-chain amino acids in decompensated cirrhotic patients

Hepatology Research

Volumn 37, Issue 12, 2007, Pages 1062-1067

  Nakamura, Ikuo ^a,b   Ochiai, Kaori ^b   Imai, Yasuharu ^a   Moriyasu, Fuminori ^a   Imawari, Michio ^c  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Branched chain amino acids (BCAA); Decompensated liver cirrhosis; Host defense mechanisms; Innate immunity; Natural killer (NK) cell activity of lymphocytes; Phagocytic function of neutrophils

Indexed keywords

ALBUMIN; BRANCHED CHAIN AMINO ACID; CHROMIUM 51; ISOLEUCINE; LEUCINE; LIVACT; MICROSPHERE; UNCLASSIFIED DRUG; VALINE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CELL STRAIN K 562; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HOST RESISTANCE; HUMAN; HUMAN CELL; INCUBATION TIME; INFECTION RESISTANCE; INNATE IMMUNITY; LIVER CIRRHOSIS; LYMPHOCYTE FUNCTION; MALE; NATURAL KILLER CELL; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK REDUCTION; TARGET CELL; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 35649026745     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00166.x     Document Type: Article

References (23)

1. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984; 4: 53-8.
2. Barnes PF, Arevalo C, Chan LS, Wong SF, Reynolds TB. A prospective evaluation of bacteremic patients with chronic liver disease. Hepatology 1988; 8: 1099-103.
3. Hoefs JC. Spontaneous bacterial peritonitis: Prevention and therapy [editorial]. Hepatology 1990; 12: 776-81.
4. Rajkovic IA, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing, and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 1986; 6: 252-62.
5. Fiuza C, Salcedo M, Clemente G, Tellado JM. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 2000; 182: 526-33.
6. Nakamura T, Morizane T, Watanabe T et al. Decreased natural killer activity in patients with liver cirrhosis. Int J Cancer 1983; 32: 573-5.
7. Laso FJ, Madruga JI, Girón J et al. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption. Hepatology 1997; 25: 1096-100.
8. Chuang WL, Liu HW, Chang WY, Chen SC, Hsieh MY, Wang LY. Natural killer cell activity in patients with liver cirrhosis relative to severity of liver damage. Dig Dis Sci 1991; 36: 299-302.
9. Meier UC, Owen RE, Taylor E et al. Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J Virol 2005; 79: 12365-74.
10. Par G, Rukavina D, Podack ER et al. Decrease in CD3-negative-CD8dim (+) and Vdelta2/Vgamma9 TcR (+) peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection. J Hepatol 2002; 37: 514-22.
11. Yoshida T, Muto Y, Moriwaki H, Yamamoto M. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. Gastroenterol Jpn 1989; 24: 692-8.
12. Bianchi GP, Marchesini G, Zoli M, Abbiati R, Ferrario A, Pisi E. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: Effects on prolactin and estradiol levels. Hepatogastroenterology 1992; 39: 443-6.
13. Habu D, Nishiguchi S, Nakatani S et al. Effect of oral supplementation with branched-chain amino acid granules on serum albumin level in the early stage of cirrhosis: A randomized pilot trial. Hepatol Res 2003; 25: 312-18.
14. Muto Y, Sato S, Watanabe A et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005; 3: 705-13.
15. Ijichi C, Matsumura T, Tsuji T, Eto Y. Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system. Biochem Biophys Res Commun 2003; 303: 59-64.
16. Steinkamp JA, Wilson JS, Saunders GC, Stewart CC. Phagocytosis: Flow cytometric quantitation with fluorescent microspheres. Science 1982; 215: 64-6.
17. Abo T, Balch CM. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 1981; 127: 1024-9.
18. Nakamura I, Ochiai K, Imawari M. Phagocytic function of neutrophils of patients with decompensated liver cirrhosis is restored by oral supplementation of branched-chain amino acids. Hepatol Res 2004; 29: 207-11.
19. Najjar VA, Nishioka K. "Tuftsin": A natural phagocytosis stimulating peptide. Nature 1970; 228: 672-3.
20. Trevisani F, Castelli E, Foschi FG et al. Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome. Gut 2002; 50: 707-12.
21. Muto Y, Sato S, Watanabe A et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 2006; 35: 204-14.
22. Wu J, Lanier LL. Natural killer cells and cancer. Adv Cancer Res 2003; 90: 127-56.
23. Koziel MJ. NK cells: Natural born killers in the conflict between humans and HCV. Hepatology 2006; 43: 395-7.